Trial NCT02041299

View at ClinicalTrials.gov 
Org. Study IDs: LA38-0411

Last trial update was posted on 2021-08-10

MeSH Interventions

Deferiprone Deferoxamine

MeSH Conditions

Anemia Anemia, Sickle Cell Iron Overload

Other Conditions

Other Anemias Sickle Cell Disease

Stopping Reasons

Difficulties with additional recruitment as pool of potential patients was exhausted, and sufficient information for determination of study outcome measure was already obtained

Limitations And Caveats

The trial was terminated early as the pool of potential participants was exhausted and it was determined that the number of patients already randomized would be sufficient to assess the primary endpoint.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID